About AVT
Browse Articles
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 24 Issue 7 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 2310 results:

Case report

Combination antiviral therapy with lopinavir/ritonavir, arbidol and interferon-α1b for COVID-19

Xiangyang Xie, Yuanliang Jiang, Yuan Zeng, Hui Liu

Antiviral Therapy 2020; 25:233-239

Short communication

Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system

Michael A Jarvis, Frederick A Hansen, Kyle Rosenke, Elaine Haddock, Christopher Rollinson, Simon Rule, Graham Sewell, Andrew Hughes, Heinz Feldmann

Antiviral Therapy 2020; 25:223-231

Original article

Hepatitis B core-related antigen levels predict pegylated interferon-α therapy response in HBeAg-positive chronic hepatitis B

Boris JB Beudeker, Zwier MA Groothuismink, Robert A de Man, Harry LA Janssen, Annemiek A van der Eijk, Andre Boonstra, Milan J Sonneveld

Antiviral Therapy 2020; 25:217-222

Original article

Dynamics of HBV surface antigen related end points in chronic hepatitis B infection: a systematic review and meta-analysis

Yusi Chen, Justin Jinhui Li, Rong Chen, Gailing Li, Jia Ji

Antiviral Therapy 2020; 25:203-215

Original article

DAA-based treatment for HIV–HCV-coinfected patients: analysis of factors of sustained virological response in a real-life study

Loredana Alessio, Lorenzo Onorato, Vincenzo Sangiovanni, Francesco Borrelli, Elio Manzillo, Vincenzo Esposito, Filomena Simeone, Salvatore Martini, Nicolina Capoluongo, Sebastiano Leone, Giovanni Di Filippo, Maurizio D’Abbraccio, Lucia Aprea, Angelo Salomone Megna, Eugenio Milano, Viviana Rizzo, Annalisa Saracino, Nicola Coppola

Antiviral Therapy 2020; 25:193-201


The effects of nucleoside/nucleotide analogues on host immune cells: the baseline for future immune therapy for HBV?

Lauke L Boeijen, Michelle Spaan, André Boonstra

Antiviral Therapy 2020; 25:181-191

Original article

Safety, pharmacokinetics and pharmacodynamics of selgantolimod, an oral Toll-like receptor 8 agonist: a Phase Ia study in healthy subjects

Maribel Reyes, Justin D Lutz, Audrey H Lau, Anuj Gaggar, Ethan P Grant, Adarsh Joshi, Richard L Mackman, John Ling, Susanna K Tan, Natarajan Ayithan, Stephane Daffis, Jacky Woo, Peiwen Wu, Tina Lam, Simon P Fletcher, Shyamasundaran Kottilil, Bhawna Poonia, Edward J Gane, Anita Mathias, Polina German

Antiviral Therapy 2020; 25:171-180

Original article

Activation of HIV-specific CD8+ T-cells from HIV+ donors by vesatolimod

Renee R Ram, Paul Duatschek, Nicolas Margot, Michael Abram, Romas Geleziunas, Joseph Hesselgesser, Christian Callebaut

Antiviral Therapy 2020; 25:163-169

Original article

Antiviral activity of PLK1-targeting siRNA delivered by lipid nanoparticles in HBV-infected hepatocytes

Adrien Foca, Ammen Dhillon, Thomas Lahlali, Julie Lucifora, Anna Salvetti, Michel Rivoire, Amy Lee, David Durantel

Antiviral Therapy 2020; 25:151-162

Original article

Factors influencing hair lamivudine concentration among people living with HIV in Guangxi, China

Quan Zhang, Xiaoming Li, Shan Qiao, Zhiyong Shen, Yuejiao Zhou

Antiviral Therapy 2020; 25:143-149

Copyright © 2021 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.